» Articles » PMID: 20101720

Neuropathology of Alzheimer's Disease

Overview
Journal Mt Sinai J Med
Specialty General Medicine
Date 2010 Jan 27
PMID 20101720
Citations 304
Authors
Affiliations
Soon will be listed here.
Abstract

Alois Alzheimer first pointed out that the disease which would later bear his name has a distinct and recognizable neuropathological substrate. Since then, much has been added to our understanding of the pathological lesions associated with the condition. The 2 primary cardinal lesions associated with Alzheimer's disease are the neurofibrillary tangle and the senile plaque. The neurofibrillary tangle consists of abnormal accumulations of abnormally phosphorylated tau within the perikaryal cytoplasm of certain neurons. The senile plaque consists of a central core of beta-amyloid, a 4-kD peptide, surrounded by abnormally configured neuronal processes or neurites. Other neuropathological lesions are encountered in cases of Alzheimer's disease, but the disease is defined and recognized by these 2 cardinal lesions. Other lesions include poorly understood changes such as granulovacuolar degeneration and eosinophilic rodlike bodies (Hirano bodies). The loss of synaptic components is a change that clearly has a significant impact on cognitive function and represents another important morphological alteration. It is important to recognize that distinguishing between Alzheimer's disease, especially in its early stages, and normal aging may be very difficult, particularly if one is examining the brains of patients who died at an advanced old age. It is also noted that instances of pure forms of Alzheimer's disease, in the absence of other coexistent brain disease processes, such as infarctions or Parkinson's disease-related lesions, are relatively uncommon, and this must be taken into account by researchers who employ postmortem brain tissues for research.

Citing Articles

Preclinical Alzheimer's disease shows alterations in circulating neuronal-derived extracellular vesicle microRNAs in a multiethnic cohort.

Reho P, Kalia V, Jackson G, Wang F, Eiten E, Brennan K Alzheimers Dement. 2025; 21(3):e70050.

PMID: 40042514 PMC: 11881609. DOI: 10.1002/alz.70050.


Interaction of genetic variants and methylation in transcript-level expression regulation in Alzheimer's disease by multi-omics data analysis.

Han S, Cho S, Choi W, Eilbeck K, Coon H, Nho K BMC Genomics. 2025; 26(1):170.

PMID: 39979805 PMC: 11844006. DOI: 10.1186/s12864-025-11362-x.


Towards realistic simulation of disease progression in the visual cortex with CNNs.

Moore J, Kang C, Vigneshwaran V, Stanley E, Memon A, Wilms M Sci Rep. 2025; 15(1):6099.

PMID: 39972104 PMC: 11839997. DOI: 10.1038/s41598-025-89738-y.


Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review.

Conic J, Chetty A, Chen L, Marsh A, Barry S, Pattabhi R Aging Med (Milton). 2025; 8(1):e70004.

PMID: 39968005 PMC: 11833297. DOI: 10.1002/agm2.70004.


Diamagnetic Signature of Beta-Amyloid (Aβ) and Tau (τ) Tangle Pathology in Alzheimer's Disease: A Review.

Ghaderi S, Mohammadi S, Fatehi F Aging Med (Milton). 2025; 8(1):e70006.

PMID: 39949469 PMC: 11817029. DOI: 10.1002/agm2.70006.


References
1.
Scheff S, Price D, Sparks D . Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex. Neurobiol Aging. 2001; 22(3):355-65. DOI: 10.1016/s0197-4580(01)00222-6. View

2.
Masliah E, Terry R, DeTeresa R, Hansen L . Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett. 1989; 103(2):234-9. DOI: 10.1016/0304-3940(89)90582-x. View

3.
Scheff S, Sparks L, Price D . Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease. Ann Neurol. 1993; 34(3):356-61. DOI: 10.1002/ana.410340309. View

4.
Lee V, Balin B, Otvos Jr L, Trojanowski J . A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 1991; 251(4994):675-8. DOI: 10.1126/science.1899488. View

5.
Hyman B, Van Hoesen G, Beyreuther K, Masters C . A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles. Neurosci Lett. 1989; 101(3):352-5. DOI: 10.1016/0304-3940(89)90559-4. View